Aptevo Therapeutics Inc (APVO)

Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	4.48% 3.752	3.591	3.887	5.462	4.168
Operating Income/Loss	9.38% -6.983	-6.384	-6.561	-8.178	-7.756
Income/Loss From Continuing Operations Before Tax	10.30% -6.834	-6.196	-6.334	-7.948	2.773
Income/Loss From Continuing Operations After Tax	10.30% -6.834	-6.196	-6.334	-7.948	1.827
Income/Loss From Discontinued Operations, Net Of Tax	100.00% -	0.293	-	-	0.946
Net Income/Loss	15.77% -6.834	-5.903	-6.334	-7.948	2.773
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	78.73% 0.6867	3.2281	12.58	6.4822	7.0223
Diluted Average Shares	78.73% 0.6867	3.2281	12.58	6.4822	7.0223
Basic Earnings Per Share	7,007% -9.95	-0.14	-0.50	-1.23	0.39
Diluted Earnings Per Share	7,007% -9.95	-0.14	-0.50	-1.23	0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-